Skip to the main content.

Cell and Gene Therapy Series. Part 4 - Managing costs and scale-up risks for medical devices

Dr. Dave Seaward : 28 February 2022

Cell and Gene Therapy Series. Part 4 - Managing costs and scale-up risks for medical devices

As we continue to explore the world of cell and gene therapy, we now take a look at managing costs and scale up risks for medical devices.

Author Dave Seward, discusses how the principles of Quality by Design (QbD) and Design for Manufacture (DfM) can be applicable to ATMPs. Read this blog now!
Precision Blister Filling: Ensuring Consistent Dose Delivery in DPIs

Precision Blister Filling: Ensuring Consistent Dose Delivery in DPIs

Tom Bailey: 21 November 2025

Read More
Advancing DPI blister filling: from the original invention to the latest technology.

Advancing DPI blister filling: from the original invention to the latest technology.

Carl Jones: 14 November 2025

Our DPI blister filling capabilities draw on long-standing experience, our founder, Tom Bailey, is one of the named inventors of the DPI filling...

Read More
Behind the scenes of 3P innovation's Customer Care team

Behind the scenes of 3P innovation's Customer Care team

Picture of Georgia Lewis-Marston Georgia Lewis-Marston: 17 October 2025

This week, I had the chance to sit down with Paul Beard, Operations Director at 3P innovation, to explore what truly distinguishes our Customer Care...

Read More